UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006053 |
|---|---|
| Receipt number | R000007162 |
| Scientific Title | Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Early Breast Cancer |
| Date of disclosure of the study information | 2011/07/28 |
| Last modified on | 2023/08/07 09:15:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/07/27 15:44:29 | ||
| 2 | Update | 2014/07/30 15:52:01 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 3 | Update | 2014/07/30 15:52:57 | Email TEL |
|
| 4 | Update | 2018/08/01 13:17:41 | Name of primary person or sponsor Organization |
|
| 5 | Update | 2023/08/07 09:04:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 6 | Update | 2023/08/07 09:13:48 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 7 | Update | 2023/08/07 09:15:01 | Recruitment status Date of IRB Anticipated trial start date |
